Editorials
Vol. 1 No. 3 (2022)
Well begun is half done
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 14 December 2022
1571
Views
185
Downloads
Authors
In these days preceding Christmas festivities and introducing us to the new year, we close the volume of the first year of our journal Bleeding, Thrombosis and Vascular Biology (BTVB) [...].
Downloads
Download data is not yet available.
Citations
.
How to Cite
1.
de Gaetano G. Well begun is half done. Bleeding Thromb Vascul Biol [Internet]. 2022 Dec. 14 [cited 2025 Oct. 25];1(3). Available from: https://www.btvb.org/btvb/article/view/61
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- CO42 | Oxidative stress may contribute to enhanced thrombopoiesis through miR-150: implications for aspirin response , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO49 | Use of emicizumab in two patients with acquired hemophilia A: a new therapeutic approach , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO43 | Early platelet dysfunction in sepsis: an ICU pilot study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO45 | Role of urinary 11-dehydro-thromboxane B2 as a predictor of preeclampsia in pregnant high-risk women on low-dose aspirin treatment , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO56 | Safety of anticoagulant treatment in patients with splanchnic vein thrombosis and history of portal hypertension-related bleeding , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO46 | Comparison of reticulated platelet procoagulant role in liver cirrhosis vs. fibrosis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO64 | A silent hemorrhage in the immuno-thrombotic chaos of antiphospholipid syndrome , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO47 | Genetic characterization of the KIV2 LPA polymorphism in subjects with bicuspid aortic valve with different clinical complications , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO65 | Utilization of emicizumab in acquired hemophilia A: a case report , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO49 | The burden of cerebral small vessel disease in ITTP patients from acute phase to remission , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
You may also start an advanced similarity search for this article.
